跳至主要内容
临床试验/NCT07032220
NCT07032220进行中(未招募)不适用

Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study

Fujian Medical University Union Hospital1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2024年12月9日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
175
试验地点
1
主要终点
By analyzing the detection rate of TAD, FNR and NPV, the feasibility and accuracy of this method in evaluating axillary lymph nodes of breast cancer patients after neoadjuvant therapy were evaluated.

研究概览

简要总结

In this study, following the full informed consent of patients regarding the safety and potential benefits of the new intervention regimen, pathologically confirmed lymph nodes were pre-labeled with carbon nanoparticles prior to neoadjuvant chemotherapy. This was done to investigate the detection rate of carbon nanoparticle-labeled lymph nodes and to assess the stability and safety of carbon nanoparticles. Additionally, the dye single tracer method was employed for sentinel lymph node biopsy to evaluate the false-negative rate of TAD. This is an open-label, single-arm, multi-center prospective clinical trial. The primary objectives of this study are to evaluate the accuracy, feasibility, and safety of this method, thereby improving the quality of life and reducing postoperative complications for breast cancer patients while ensuring treatment efficacy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • women aged 18-70 years
  • The primary breast lesion was confirmed as invasive breast cancer by core needle biopsy
  • Axillary lymph node metastasis confirmed by fine needle aspiration or core needle biopsy
  • plan to undergo neoadjuvant chemotherapy
  • operable breast cancer
  • Patients with good heart, lung, liver, and kidney function are suitable for surgery
  • Informed consent

排除标准

  • Surgery is not planned or impossible
  • Metastasis of supraclavicular lymph nodes
  • distant metastasis, excluding bone metastasis
  • previous ipsilateral axillary surgery or radiotherapy
  • Due to personal or family factors, the patient is unable to cooperate with the surgical treatment recommended by the doctor according to the condition (breast conserving surgery or radical surgery).
  • Patients with severe heart and lung diseases, uncontrolled infectious diseases and other non-tumor related diseases could not tolerate comprehensive treatment such as surgery and chemotherapy
  • Unable to sign the informed consent form due to mental illness or other reasons
  • Poor medical compliance, and the study group believed that the patients could not complete the trial treatment process and follow-up according to the standard

研究组 & 干预措施

Feasibility and Accuracy of Targeted Axillary Dissection of Carbon Tattooing

Experimental

干预措施: carbon suspension (Drug)

结局指标

主要结局

By analyzing the detection rate of TAD, FNR and NPV, the feasibility and accuracy of this method in evaluating axillary lymph nodes of breast cancer patients after neoadjuvant therapy were evaluated.

时间窗: 24 months

次要结局

  • The feasibility and accuracy of TLNB and SLNB in axillary lymph node evaluation were evaluated by analyzing the detection rate of TLNB and SLNB, FNR and NPV.(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chuan Wang

archiater

Fujian Medical University Union Hospital

研究点 (1)

Loading locations...

相似试验

Application of Targeted Axillary Lymph Node... | 临床试验